Literature DB >> 26200986

Targeting Antithrombin to Treat Hemophilia.

Margaret V Ragni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200986     DOI: 10.1056/NEJMcibr1505657

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Non-factor replacement therapy for haemophilia: a current update.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2018-02-14       Impact factor: 3.443

Review 2.  Novel therapies and current clinical progress in hemophilia A.

Authors:  Pauline Balkaransingh; Guy Young
Journal:  Ther Adv Hematol       Date:  2017-12-28

3.  Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban.

Authors:  Armando Tripodi; Ida Martinelli; Veena Chantarangkul; Marigrazia Clerici; Andrea Artoni; Serena Passamonti; Flora Peyvandi
Journal:  Int J Hematol       Date:  2015-11-19       Impact factor: 2.490

Review 4.  An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B.

Authors:  Nicoletta Machin; Margaret V Ragni
Journal:  J Blood Med       Date:  2018-08-22

Review 5.  Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.

Authors:  Steven P Grover; Nigel Mackman
Journal:  Front Cardiovasc Med       Date:  2022-05-03

Review 6.  Potential role of a new PEGylated recombinant factor VIII for hemophilia A.

Authors:  Tung Thanh Wynn; Burak Gumuscu
Journal:  J Blood Med       Date:  2016-06-20

7.  In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy.

Authors:  Jeong Pil Han; MinJeong Kim; Beom Seok Choi; Jeong Hyeon Lee; Geon Seong Lee; Michaela Jeong; Yeji Lee; Eun-Ah Kim; Hye-Kyung Oh; Nanyeong Go; Hyerim Lee; Kyu Jun Lee; Un Gi Kim; Jae Young Lee; Seokjoong Kim; Jun Chang; Hyukjin Lee; Dong Woo Song; Su Cheong Yeom
Journal:  Sci Adv       Date:  2022-01-21       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.